Works matching IS 03407004 AND DT 2022 AND VI 71 AND IP 11

Results: 21

Correction to: Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models.

Published in:

2022

By:

Žilionytė, Karolina;
Bagdzevičiūtė, Ugnė;
Mlynska, Agata;
Urbštaitė, Elena;
Paberalė, Emilija;
Dobrovolskienė, Neringa;
Krasko, Jan Aleksander;
Pašukonienė, Vita

Publication type:

Correction Notice

Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2791, doi. 10.1007/s00262-022-03206-4

By:

Talb, Jamila;
Takam Kamga, Paul;
Mayenga, Marie;
Costantini, Adrien;
Julié, Catherine;
Dumenil, Coraline;
Dumoulin, Jennifer;
Ouaknine, Julia;
Giraud, Violaine;
Dujon, Cécile;
Azarian, Reza;
Glaser, Claire;
Emile, Jean-François;
Giroux Leprieur, Etienne

Publication type:

Article

Clinical and molecular correlates of response to immune checkpoint blockade in urothelial carcinoma with liver metastasis.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2815, doi. 10.1007/s00262-022-03204-6

By:

Yoshida, Takashi;
Ohe, Chisato;
Ito, Katsuhiro;
Takada, Hideaki;
Saito, Ryoichi;
Kita, Yuki;
Sano, Takeshi;
Tsuta, Koji;
Kinoshita, Hidefumi;
Kitamura, Hiroshi;
Nishiyama, Hiroyuki;
Kobayashi, Takashi

Publication type:

Article

Establishment of a mechanism-based in vitro coculture assay for evaluating the efficacy of immune checkpoint inhibitors.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2777, doi. 10.1007/s00262-022-03201-9

By:

Kim, Myeong Joon;
Hong, Kyeong Hee;
Lee, Bo Ryeong;
Ha, Sang-Jun

Publication type:

Article

Role of the cGAS-STING pathway in regulating the tumor-immune microenvironment in dMMR/MSI colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2765, doi. 10.1007/s00262-022-03200-w

By:

Kaneta, Akinao;
Nakajima, Shotaro;
Okayama, Hirokazu;
Matsumoto, Takuro;
Saito, Katsuharu;
Kikuchi, Tomohiro;
Endo, Eisei;
Ito, Misato;
Mimura, Kosaku;
Kanke, Yasuyuki;
Saito, Motonobu;
Saze, Zenichiro;
Fujita, Shotaro;
Sakamoto, Wataru;
Onozawa, Hisashi;
Momma, Tomoyuki;
Ohki, Shinji;
Kono, Koji

Publication type:

Article

The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2731, doi. 10.1007/s00262-022-03199-0

By:

Gauci, Marie-Léa;
Giustiniani, Jérôme;
Lepelletier, Clémence;
Garbar, Christian;
Thonnart, Nicolas;
Dumaz, Nicolas;
Foussat, Arnaud;
Lebbé, Céleste;
Bensussan, Armand;
Marie-Cardine, Anne

Publication type:

Article

Serial interferon-gamma release assay in lung cancer patients receiving immune checkpoint inhibitors: a prospective cohort study.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2757, doi. 10.1007/s00262-022-03198-1

By:

Fujita, Kohei;
Elkington, Paul;
Redelman-Sidi, Gil;
Kanai, Osamu;
Yamamoto, Yuki;
Imakita, Takuma;
Okamura, Misato;
Nakatani, Koichi;
Mio, Tadashi

Publication type:

Article

Tumor-derived exosomes drive pre-metastatic niche formation in lung via modulating CCL1<sup>+</sup> fibroblast and CCR8<sup>+</sup> Treg cell interactions.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2717, doi. 10.1007/s00262-022-03196-3

By:

Wang, Ming;
Qin, Zhongyu;
Wan, Jiajia;
Yan, Yan;
Duan, Xixi;
Yao, Xiaohan;
Jiang, Ziming;
Li, Wenqing;
Qin, Zhihai

Publication type:

Article

Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumor.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2801, doi. 10.1007/s00262-022-03195-4

By:

Wang, Yuedi;
Gao, Yiyuan;
Niu, Congyi;
Wang, Bo;
Zhao, Shushu;
Roex, Gils;
Qian, Jiawen;
Qie, Jingbo;
Chen, Lin;
Yi, Chenhe;
Anguille, Sébastien;
Liu, Jie;
Luo, Feifei;
Chu, Yiwei

Publication type:

Article

Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2743, doi. 10.1007/s00262-022-03194-5

By:

Nagata, Yasuhiro;
Kageyama, Shinichi;
Ishikawa, Takeshi;
Kokura, Satoshi;
Okayama, Tetsuya;
Abe, Tetsuya;
Murakami, Masahiko;
Otsuka, Koji;
Ariyoshi, Tomotake;
Kojima, Takashi;
Taniguchi, Ken;
Kobayashi, Shinichiro;
Shimada, Hideaki;
Yajima, Satoshi;
Suzuki, Takashi;
Hirano, Satoshi;
Tsuchikawa, Takahiro;
Shichinohe, Toshiaki;
Ueda, Shugo;
Kanetaka, Kengo

Publication type:

Article

CXCL9-modified CAR T cells improve immune cell infiltration and antitumor efficacy.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2663, doi. 10.1007/s00262-022-03193-6

By:

Tian, Yonggui;
Wen, Chunli;
Zhang, Zhen;
Liu, Yanfen;
Li, Feng;
Zhao, Qitai;
Yao, Chang;
Ni, Kaiyuan;
Yang, Shengli;
Zhang, Yi

Publication type:

Article

Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2691, doi. 10.1007/s00262-022-03190-9

By:

Žilionytė, Karolina;
Bagdzevičiūtė, Ugnė;
Mlynska, Agata;
Urbštaitė, Elena;
Paberalė, Emilija;
Dobrovolskienė, Neringa;
Krasko, Jan Aleksander;
Pašukonienė, Vita

Publication type:

Article

OIT3 mediates macrophage polarization and facilitates hepatocellular carcinoma progression.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2677, doi. 10.1007/s00262-022-03188-3

By:

Yang, Shuai;
Zhang, Jiangang;
Xu, Yanquan;
Wang, Jingchun;
Zhao, Huakan;
Lei, Juan;
Zhou, Yu;
Chen, Yu;
Wu, Lei;
Zhou, Mingyue;
Zheng, Lu;
Ji, Xiaohui;
Li, Yongsheng

Publication type:

Article

The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2645, doi. 10.1007/s00262-022-03187-4

By:

Shinchi, Yusuke;
Ishizuka, Shiho;
Komohara, Yoshihiro;
Matsubara, Eri;
Mito, Remi;
Pan, Cheng;
Yoshii, Daiki;
Yonemitsu, Kimihiro;
Fujiwara, Yukio;
Ikeda, Koei;
Tamada, Koji;
Sakagami, Takuro;
Suzuki, Makoto

Publication type:

Article

Lenvatinib plus pembrolizumab for systemic therapy-naïve and -experienced unresectable hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2631, doi. 10.1007/s00262-022-03185-6

By:

Wu, Chi-Jung;
Lee, Pei-Chang;
Hung, Ya-Wen;
Lee, Chieh-Ju;
Chi, Chen-Ta;
Lee, I-Cheng;
Hou, Ming-Chih;
Huang, Yi-Hsiang

Publication type:

Article

Evaluation of the efficacy and safety of TAS0313 in adults with recurrent glioblastoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2703, doi. 10.1007/s00262-022-03184-7

By:

Narita, Yoshitaka;
Okita, Yoshiko;
Arakawa, Yoshiki

Publication type:

Article

Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2583, doi. 10.1007/s00262-022-03183-8

By:

Prasad, Mukul;
Ponnalagu, Sashigala;
Zeng, Qun;
Luu, Khang;
Lang, Si Min;
Wong, Hiu Yi;
Cheng, Man Si;
Wu, Meihui;
Mallilankaraman, Karthik;
Sobota, Radoslaw Mikolaj;
Lim, Yan Ting;
Wang, Loo Chien;
Goh, Chuan Keng;
Tay, Kai Xun Joshua;
Loh, Kwok Seng;
Wang, Cheng-I.;
Lee, Wen-Hsien;
Goh, Boon Cher;
Lim, Chwee Ming;
Schwarz, Herbert

Publication type:

Article

Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2609, doi. 10.1007/s00262-022-03180-x

By:

Gefard-Gontier, E.;
Markich, R.;
Zysman, M.;
Veillon, R.;
Daste, A.;
Domblides, C.;
Sionneau, B.;
Gross-Goupil, M.;
Lefort, F.;
Prey, S.;
Dutriaux, C.;
Gerard, E.;
Dousset, L.;
Pham-Ledard, A.;
Beylot-Barry, M.;
Schaeverbeke, T.;
Kostine, M.

Publication type:

Article

Camrelizumab combined with apatinib and S-1 as second-line treatment for patients with advanced gastric or gastroesophageal junction adenocarcinoma: a phase 2, single-arm, prospective study.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2597, doi. 10.1007/s00262-022-03174-9

By:

Jing, Chao;
Wang, Junyun;
Zhu, Mingyue;
Bai, Zhigang;
Zhao, Baoyi;
Zhang, Jun;
Yin, Jie;
Yang, Xiaobao;
Liu, Zongzhi;
Zhang, Zhongtao;
Deng, Wei

Publication type:

Article

Tafasitamab mediates killing of B-cell non-Hodgkin's lymphoma in combination with γδ T cell or allogeneic NK cell therapy.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2829, doi. 10.1007/s00262-022-03165-w

By:

Her, Jung Hyun;
Pretscher, Dominik;
Patra-Kneuer, Maria;
Schanzer, Juergen;
Cho, Sung Yoo;
Hwang, Yu Kyeong;
Hoeres, Timm;
Boxhammer, Rainer;
Heitmueller, Christina;
Wilhelm, Martin;
Steidl, Stefan;
Endell, Jan

Publication type:

Article

Altered immunity to microbiota, B cell activation and depleted γδ/resident memory T cells in colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2619, doi. 10.1007/s00262-021-03135-8

By:

Noble, Alistair;
Pring, Edward T.;
Durant, Lydia;
Man, Ripple;
Dilke, Stella M.;
Hoyles, Lesley;
James, Steve A.;
Carding, Simon R.;
Jenkins, John T.;
Knight, Stella C.

Publication type:

Article